Abstract
We studied HBV infection in 34 HIV-2–infected patients followed-up in Marseilles. Ten (29%) patients were chronically-infected with HBV, which represents a three-times higher rate than in HIV-1-infected patients in Europe. HBV occult infection was diagnosed in two patients. HBV genotype E was found in seven patients; its specificities and the reciprocal influence of HIV-2/HBV-co-infection remain to be evaluated.
Abbreviations
- HBeAg:
-
HBe antigen
- HBsAg:
-
HBs antigen
- HBV:
-
hepatitis B virus
- HIV-1:
-
human immunodeficiency virus type 1
- HIV-2:
-
human immunodeficiency virus type 2
References
Konopnicki D, Mocroft A, de Wit S, et al. 2005; Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19(6):593–601
Ejele OA, Nwauche CA, Erhabor O, 2004; The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria. Niger J Med 13(2):175–179
Mulders MN, Venard V, Njayou M, et al. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004; 190(2): 400–408. Epub 2004 Jun 22
Rouet F, Chaix ML, Inwoley A, et al. 2004; HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d’Ivoire: The ANRS 1236 study. J Med Virol 74(1):34–40
Reeves JD, Doms RW, 2000; Human immunodeficiency virus type 2. J Gen Virol 83(Pt 6):1253–1265
Colson P, Henry M, Tivoli N, et al. 2005; Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France. J Med Virol 75(3):381–390
Delfraissy JF, Epidémiologie. In: Flammarion M-S (ed), Prise en charge thérapeutique des personnes infectées par le VIH: Recommandations du groupe d’experts. 2004: 17–42
Gerolami R, Henry M, Borentain P, Colson P, Botta D, Tamalet C. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of␣hepatitis B virus DNA after immunosuppressive treatment. Clin Infect Dis 2005; 40(4):e24–27. Epub 2005 Jan 21
Hunt CM, McGill JM, Allen MI, Condreay LD., 2000; Clinical relevance of hepatitis B viral mutations. Hepatology 31(5):1037–1044
Matheron S, Pueyo S, Damond F, et al. 2003; Factors associated with clinical progression in HIV-2 infected-patients: The French ANRS cohort. AIDS 17(18):2593–2601
Koyanagi T, Nakamuta M, Sakai H, et al. 2000; Analysis of HBs antigen negative variant of hepatitis B virus: Unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene. Med Sci Monit 6(6):1165–1169
Protzer-Knolle U, Naumann U, Bartenschlager R, et al. 1998; Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27(1):254–263
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Colson, P., Henry, M., Motte, A. et al. Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France. Eur J Epidemiol 21, 615–618 (2006). https://doi.org/10.1007/s10654-006-9039-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-006-9039-4